Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AG's Other Operating Expense for the
six
months ended in Jun. 2026 was €1,496 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was €2,929 Mil.
DSM-Firmenich AG's quarterly Other Operating Expense
declined
from Jun. 2025 (€1,465 Mil) to Dec. 2025 (€1,433 Mil) but then
increased
from Dec. 2025 (€1,433 Mil) to Jun. 2026 (€1,496 Mil).
DSM-Firmenich AG's annual Other Operating Expense
increased
from Dec. 2023 (€-61 Mil) to Dec. 2024 (€-16 Mil) but then
declined
from Dec. 2024 (€-16 Mil) to Dec. 2025 (€-21 Mil).
DSM-Firmenich AG Other Operating Expense Related Terms
DSM-Firmenich AG Other Operating Expense Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2,929 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of €2,929 Mil mean?
DSM-Firmenich AG (LTS:0AC9) has a Other Operating Expense of €2,929 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's Other Operating Expense too high?
DSM-Firmenich AG's current Other Operating Expense is €2,929 Mil. Overall, DSM-Firmenich AG has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Other Operating Expense compare to LIN and SHW?
DSM-Firmenich AG's Other Operating Expense of €2,929 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current Other Operating Expense is €2,929 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (LTS:0AC9) is currently considered Modestly Overvalued. The stock's GF Value™ is €83.48, compared to a current price of €93.09 — trading 11.5% above its estimated fair value. The current Other Operating Expense is €2,929 Mil. DSM-Firmenich AG's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For DSM-Firmenich AG (LTS:0AC9), the current Other Operating Expense is €2,929 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (LTS:0AC9) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of €93.09 is trading 11.5% above its estimated GF Value™ of €83.48.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for LTS:0AC9:
Other Operating Expense: €2,929 Mil
GF Value™: €83.48 vs. price of €93.09 (11.5% above fair value)
No single metric tells the full story. See the LTS:0AC9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
60GF Score
Get the complete analysis for LTS:0AC9
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0AC9 has been successfully added to your 
